These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32706964)

  • 41. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.
    Bischoff F; Berthelot D; De Cleyn M; Macdonald G; Minne G; Oehlrich D; Pieters S; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter I; Zaja M; Borghys H; Masungi C; Mercken M; Gijsen HJ
    J Med Chem; 2012 Nov; 55(21):9089-106. PubMed ID: 22650177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Γ-secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment.
    Li T; Huang Y; Jin S; Ye L; Rong N; Yang X; Ding Y; Cheng Z; Zhang J; Wan Z; Harrison DC; Hussain I; Hall A; Lee DH; Lau LF; Matsuoka Y
    J Neurochem; 2012 Apr; 121(2):277-86. PubMed ID: 22035227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iminoheterocycles as gamma-secretase modulators.
    Caldwell JP; Bennett CE; McCracken TM; Mazzola RD; Bara T; Buevich A; Burnett DA; Chu I; Cohen-Williams M; Josein H; Hyde L; Lee J; McKittrick B; Song L; Terracina G; Voigt J; Zhang L; Zhu Z
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5380-4. PubMed ID: 20724152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyridazine-derived γ-secretase modulators.
    Wan Z; Hall A; Jin Y; Xiang JN; Yang E; Eatherton A; Smith B; Yang G; Yu H; Wang J; Ye L; Lau LF; Yang T; Mitchell W; Cai W; Zhang X; Sang Y; Wang Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4016-9. PubMed ID: 21636276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gamma-secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective.
    Peretto I; La Porta E
    Curr Top Med Chem; 2008; 8(1):38-46. PubMed ID: 18220931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Pterocarpus erinaceus kino extract and its gamma-secretase inhibitory properties.
    Hage S; Stanga S; Marinangeli C; Octave JN; Dewachter I; Quetin-Leclercq J; Kienlen-Campard P
    J Ethnopharmacol; 2015 Apr; 163():192-202. PubMed ID: 25639816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability.
    Malamas MS; Robichaud A; Erdei J; Quagliato D; Solvibile W; Zhou P; Morris K; Turner J; Wagner E; Fan K; Olland A; Jacobsen S; Reinhart P; Riddell D; Pangalos M
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6597-605. PubMed ID: 20880704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. γ-Secretase and its modulators: Twenty years and beyond.
    Xia W
    Neurosci Lett; 2019 May; 701():162-169. PubMed ID: 30763650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice.
    Goldstein ME; Cao Y; Fiedler T; Toyn J; Iben L; Barten DM; Pierdomenico M; Corsa J; Prasad CV; Olson RE; Li YW; Zaczek R; Albright CF
    J Pharmacol Exp Ther; 2007 Oct; 323(1):102-8. PubMed ID: 17640949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutant presenilin 2 increases β-secretase activity through reactive oxygen species-dependent activation of extracellular signal-regulated kinase.
    Park MH; Choi DY; Jin HW; Yoo HS; Han JY; Oh KW; Han SB; Hwang DY; Hong JT
    J Neuropathol Exp Neurol; 2012 Feb; 71(2):130-9. PubMed ID: 22249458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): metabolically stable γ-secretase Inhibitors that selectively inhibit the production of amyloid-β over Notch.
    Probst G; Aubele DL; Bowers S; Dressen D; Garofalo AW; Hom RK; Konradi AW; Marugg JL; Mattson MN; Neitzel ML; Semko CM; Sham HL; Smith J; Sun M; Truong AP; Ye XM; Xu YZ; Dappen MS; Jagodzinski JJ; Keim PS; Peterson B; Latimer LH; Quincy D; Wu J; Goldbach E; Ness DK; Quinn KP; Sauer JM; Wong K; Zhang H; Zmolek W; Brigham EF; Kholodenko D; Hu K; Kwong GT; Lee M; Liao A; Motter RN; Sacayon P; Santiago P; Willits C; Bard F; Bova MP; Hemphill SS; Nguyen L; Ruslim L; Tanaka K; Tanaka P; Wallace W; Yednock TA; Basi GS
    J Med Chem; 2013 Jul; 56(13):5261-74. PubMed ID: 23713656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological properties of a novel and potent γ-secretase modulator as a therapeutic option for the treatment of Alzheimer's disease.
    Murakami K; Watanabe T; Koike T; Kamata M; Igari T; Kondo S
    Brain Res; 2016 Feb; 1633():73-86. PubMed ID: 26707977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
    Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
    J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.
    Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N
    Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of gamma-secretase inhibitors efficacious in a transgenic animal model of Alzheimer's disease.
    Asberom T; Zhao Z; Bara TA; Clader JW; Greenlee WJ; Hyde LA; Josien HB; Li W; McPhail AT; Nomeir AA; Parker EM; Rajagopalan M; Song L; Wong GT; Zhang L; Zhang Q; Pissarnitski DA
    Bioorg Med Chem Lett; 2007 Jan; 17(2):511-6. PubMed ID: 17079141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and optimization of tricyclic gamma-secretase modulators.
    Shi J; Zuev D; Xu L; Lentz KA; Grace JE; Toyn JH; Olson RE; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2016 Mar; 26(5):1498-502. PubMed ID: 26848108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.
    Lu J; Cui J; Li X; Wang X; Zhou Y; Yang W; Chen M; Zhao J; Pei G
    PLoS One; 2016; 11(11):e0166415. PubMed ID: 27835671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.
    Zhao Z; Pissarnitski DA; Josien HB; Bara TA; Clader JW; Li H; McBriar MD; Rajagopalan M; Xu R; Terracina G; Hyde L; Song L; Zhang L; Parker EM; Osterman R; Buevich AV
    Eur J Med Chem; 2016 Nov; 124():36-48. PubMed ID: 27560281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.